<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02621463</url>
  </required_header>
  <id_info>
    <org_study_id>IRB_00074281</org_study_id>
    <nct_id>NCT02621463</nct_id>
  </id_info>
  <brief_title>Electric Blower Based Ventilator Used During Procedural Sedation</brief_title>
  <official_title>Electric Blower Based Ventilator Used During Procedural Sedation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Aeronautics and Space Administration (NASA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Conduct human trials in the endoscopy suite of our continuous positive airway pressure (CPAP)&#xD;
      ventilator approach using an FDA approved ventilator.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All study procedures will be performed in adult patients following informed consent at the&#xD;
      endoscopy suite of the University of Utah Health Sciences Center in Salt Lake City, Utah. A&#xD;
      ventilation mask will be placed on the patient's face and connected to the ventilator.&#xD;
      Supplemental oxygen will be delivered by the ventilator through the mask; the concentration&#xD;
      of oxygen delivered will be left to the clinician's discretion. A modified mask with multiple&#xD;
      small leaks will be used with a standard elastomeric H-strap to secure it to the patient's&#xD;
      face.&#xD;
&#xD;
      The endoscopy suite nurse and technicians will attach all clinically necessary standard&#xD;
      sensors and connect them to the patient and monitoring system. Height, weight, and neck&#xD;
      circumference will be measured and recorded digitally on an encrypted laptop. In addition to&#xD;
      the standard of care monitors, the investigators will collect data from additional&#xD;
      non-invasive modalities and save the data to a laptop using custom software for later&#xD;
      analysis.&#xD;
&#xD;
      Pressure and flow sensors included in the ventilator will be used to monitor the patients'&#xD;
      tidal volumes and respiratory rate during the procedure. The data that will be collected and&#xD;
      recorded on the laptop will include: RIP data, mask pressure, flow, and breath rate. An&#xD;
      additional flow sensor will be placed in line with the ventilator.&#xD;
&#xD;
      The objective of this study is threefold: Demonstrate in patients undergoing procedural&#xD;
      sedation (e.g., for colonoscopy) that obstructive apnea can successfully be avoided by&#xD;
      stenting the airway open using CPAP, demonstrate that we can successfully detect periods of&#xD;
      zero ventilation, and demonstrate the functionality of the modified standard mask.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2015</start_date>
  <completion_date type="Actual">June 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Time the Patient Will Experience Apnea</measure>
    <time_frame>Duration of Diagnostic Procedure (Colonoscopy)</time_frame>
    <description>Length of time in minutes the patient experiences apnea divided by the length of time of the diagnostic procedure (Unit: %)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Apnea During Procedural Sedation</condition>
  <arm_group>
    <arm_group_label>Noninvasive Ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of the Noninvasive Ventilator (V60, Philips). The ventilator mask will be placed on the patient's face according to their comfort using an elastomeric H-strap. CPAP of 8 cmH2O (pressure) will be the starting setting for the ventilator.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Noninvasive Ventilator (V60, Philips)</intervention_name>
    <description>The clinician will determine the concentration of oxygen that shall be delivered to the patient. The ventilator is capable of providing concentrations between 21% - 100% of oxygen. Unless otherwise directed by the clinician, the default setting of 40% will be used.</description>
    <arm_group_label>Noninvasive Ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt; 18 years of age&#xD;
&#xD;
          -  undergoing a colonoscopy procedure&#xD;
&#xD;
          -  receiving registered nurse-administered procedural sedation at the University of Utah&#xD;
             Health Sciences Center&#xD;
&#xD;
          -  agree to participate&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability/refusal of subject to provide informed consent.&#xD;
&#xD;
          -  Standard colonoscopy exclusion criteria used at the GI lab at the University of Utah.&#xD;
&#xD;
          -  Pregnant patients and patients with an ASA (American Society of Anesthesiology)&#xD;
             physical status of IV or V.&#xD;
&#xD;
          -  Patients with severe medical condition(s) that in the view of the acting physician&#xD;
             prohibits participation in the study.&#xD;
&#xD;
          -  Patients with a BMI &gt; 35 will not be included in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kai Kuck, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 1, 2015</study_first_submitted>
  <study_first_submitted_qc>December 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2015</study_first_posted>
  <results_first_submitted>November 2, 2020</results_first_submitted>
  <results_first_submitted_qc>April 26, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 27, 2021</results_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Kai Kuck</investigator_full_name>
    <investigator_title>Ph.D.</investigator_title>
  </responsible_party>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 30, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT02621463/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Noninvasive Ventilation</title>
          <description>Use of the Noninvasive Ventilator (V60, Philips). The ventilator mask will be placed on the patient's face according to their comfort using an elastomeric H-strap. CPAP of 8 cmH2O (pressure) will be the starting setting for the ventilator.&#xD;
Noninvasive Ventilator (V60, Philips): The clinician will determine the concentration of oxygen that shall be delivered to the patient. The ventilator is capable of providing concentrations between 21% - 100% of oxygen. Unless otherwise directed by the clinician, the default setting of 40% will be used.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Noninvasive Ventilation</title>
          <description>Use of the Noninvasive Ventilator (V60, Philips). The ventilator mask will be placed on the patient's face according to their comfort using an elastomeric H-strap. CPAP of 8 cmH2O (pressure) will be the starting setting for the ventilator.&#xD;
Noninvasive Ventilator (V60, Philips): The clinician will determine the concentration of oxygen that shall be delivered to the patient. The ventilator is capable of providing concentrations between 21% - 100% of oxygen. Unless otherwise directed by the clinician, the default setting of 40% will be used.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Time the Patient Will Experience Apnea</title>
        <description>Length of time in minutes the patient experiences apnea divided by the length of time of the diagnostic procedure (Unit: %)</description>
        <time_frame>Duration of Diagnostic Procedure (Colonoscopy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Noninvasive Ventilation</title>
            <description>Use of the Noninvasive Ventilator (V60, Philips). The ventilator mask will be placed on the patient's face according to their comfort using an elastomeric H-strap. CPAP of 8 cmH2O (pressure) will be the starting setting for the ventilator.&#xD;
Noninvasive Ventilator (V60, Philips): The clinician will determine the concentration of oxygen that shall be delivered to the patient. The ventilator is capable of providing concentrations between 21% - 100% of oxygen. Unless otherwise directed by the clinician, the default setting of 40% will be used.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Time the Patient Will Experience Apnea</title>
          <description>Length of time in minutes the patient experiences apnea divided by the length of time of the diagnostic procedure (Unit: %)</description>
          <units>% time in apnea of total study duration</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="4" upper_limit="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participation and adverse event reporting was limited to the study intervention, mean of 24 minutes (SD 11).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Noninvasive Ventilation</title>
          <description>Use of the Noninvasive Ventilator (V60, Philips). The ventilator mask will be placed on the patient's face according to their comfort using an elastomeric H-strap. CPAP of 8 cmH2O (pressure) will be the starting setting for the ventilator.&#xD;
Noninvasive Ventilator (V60, Philips): The clinician will determine the concentration of oxygen that shall be delivered to the patient. The ventilator is capable of providing concentrations between 21% - 100% of oxygen. Unless otherwise directed by the clinician, the default setting of 40% will be used.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This was not a randomized clinical trial involving multiple facilities.&#xD;
The pharmacodynamic effect of the sedation were unknown.&#xD;
The CPAP machine and the tight-fitting mask may have provided enough of a stimulus as to maintain the patient in a lighter sedation state.&#xD;
The proprietary C-flex and Auto-Trak algorithms are integrated into the V60 ventilator and could not be disabled. The algorithms did cause some variation in pressure levels delivered to the patients.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Kai Kuck, PhD</name_or_title>
      <organization>University of Utah</organization>
      <phone>8012051010</phone>
      <email>kai.kuck@hsc.utah.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

